Search for: "Roche Laboratories, Inc."
Results 41 - 60
of 139
Sorted by Relevance
|
Sort by Date
29 Jun 2010, 6:01 pm
Reddy’s Laboratories, Ltd. et al. [read post]
30 Jun 2010, 5:52 am
Reddy's Laboratories, Ltd. et al. [read post]
19 May 2010, 6:15 am
(Patent Docs) US: CAFC affirms claim construction and corresponding summary judgment of non-infringement: Scantibodies Laboratory, Inc. v. [read post]
21 Jun 2012, 11:46 am
(f/k/a Biocraft Laboratories, Inc.)61. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on Mylan’s… [read post]
23 Dec 2009, 12:40 am
(Patent Docs) US: Science Progress article examines impact of gene patents on research (Patent Docs) US: Gene patenting debate continues: round three – Science Friday public debate on National Public Radio (Patent Docs) Products Circadin (Melatonin) – UK: IPO refuses SPC for Circadin (SPC blog) Dovonex (Calcipoltriol) – UK: EWCA upholds Leo Pharma’s patent: LEO Pharma A/S and LEO Laboratories Limited v. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb) General Biotech legislative agenda: healthcare, energy, patents and capital (IP Watch) India: Applying for patents does pay: Wockhardt wins kudos from the Indian government (SPICY IP) US: CAFC ruling in Board of Trustees of the Leland Stanford Junior University et al v Roche Molecular Systems et al - How to lose a patent? [read post]
5 Feb 2009, 6:32 am
Well-known antidepressants include Eli Lilly and Co's (LLY.N) Prozac, Pfizer Inc's (PFE.N) Zoloft, GlaxoSmithKline Plc's (GSK.L)(GSK.N) Paxil and Forest Laboratories Inc's (FRX.N) Lexapro and Celexa. [read post]
9 Dec 2009, 3:59 pm
Amgen Inc. [read post]
17 Sep 2009, 4:30 am
McNeil Laboratories, Inc., 807 F.2d 464 (5th Cir. 1987). [read post]
29 Dec 2010, 2:57 am
Highlights this week included: CAFC: Broad scope of statutory subject matter: Prometheus Laboratories, Inc. v. [read post]
6 May 2016, 12:30 pm
Hoffman-La Roche, Inc., 2007 WL 4042757, at *3 (N.D. [read post]
2 Jun 2011, 12:46 pm
Ayerst Laboratories, 548 A.2d 798, 801 & n.6 (D.C. 1988). [read post]
28 Sep 2010, 3:14 pm
Roche Holding Ltd. et al. [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy': (IP… [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in inequitable… [read post]
17 Oct 2008, 1:32 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation… [read post]
10 Jun 2012, 9:40 pm
Prometheus, Inc., decision, (see our March 20th post) and is currently under review by the U.S. [read post]
20 Jan 2011, 12:50 pm
Hoffmann-La Roche, Inc., 891 A.2d 1229, 1236 (N.J. [read post]
